- Home
- PSNYW vs CDNA Comparison
PSNYW vs CDNA Comparison
Compare PSNYW & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNYW
- CDNA
- Stock Information
- Founded
- PSNYW 2017
- CDNA 1998
- Country
- PSNYW Sweden
- CDNA United States
- Employees
- PSNYW 2547
- CDNA N/A
- Industry
- PSNYW Auto Manufacturing
- CDNA Medical Specialities
- Sector
- PSNYW Consumer Discretionary
- CDNA Health Care
- Exchange
- PSNYW Nasdaq
- CDNA Nasdaq
- Market Cap
- PSNYW 625.2M
- CDNA 712.2M
- IPO Year
- PSNYW N/A
- CDNA 2014
- Fundamental
- Price
- PSNYW $0.26
- CDNA $14.28
- Analyst Decision
- PSNYW
- CDNA Buy
- Analyst Count
- PSNYW 0
- CDNA 8
- Target Price
- PSNYW N/A
- CDNA $26.86
- AVG Volume (30 Days)
- PSNYW 43.4K
- CDNA 1.0M
- Earning Date
- PSNYW 03-06-2025
- CDNA 11-04-2025
- Dividend Yield
- PSNYW N/A
- CDNA N/A
- EPS Growth
- PSNYW N/A
- CDNA N/A
- EPS
- PSNYW N/A
- CDNA 1.00
- Revenue
- PSNYW $2,034,261,000.00
- CDNA $340,826,000.00
- Revenue This Year
- PSNYW N/A
- CDNA $12.73
- Revenue Next Year
- PSNYW $79.49
- CDNA $11.90
- P/E Ratio
- PSNYW N/A
- CDNA $14.32
- Revenue Growth
- PSNYW N/A
- CDNA 14.72
- 52 Week Low
- PSNYW $0.09
- CDNA $10.96
- 52 Week High
- PSNYW $0.61
- CDNA $26.37
- Technical
- Relative Strength Index (RSI)
- PSNYW 50.45
- CDNA 46.29
- Support Level
- PSNYW $0.23
- CDNA $14.03
- Resistance Level
- PSNYW $0.30
- CDNA $15.13
- Average True Range (ATR)
- PSNYW 0.04
- CDNA 0.64
- MACD
- PSNYW 0.00
- CDNA -0.08
- Stochastic Oscillator
- PSNYW 24.34
- CDNA 20.31
About PSNYW Polestar Automotive Holding UK PLC Class C-1 ADS (ADW)
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.